Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sandow

Showing results (171-180 of 189) with videos related to

Pageof 19
Sort By:
Nature Communications|June 21, 2020
Distinct pseudokinase domain conformations underlie divergent activation mechanisms among vertebrate MLKL orthologuesKatherine A Davies, Cheree Fitzgibbon, Samuel N Young, et al.
Nature Communications|April 14, 2021
Conformational interconversion of MLKL and disengagement from RIPK3 precede cell death by necroptosisSarah E Garnish, Yanxiang Meng, Akiko Koide, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2020
Identification of MLKL membrane translocation as a checkpoint in necroptotic cell death using MonobodiesEmma J Petrie, Richard W Birkinshaw, Akiko Koide, et al.
Nature Structural & Molecular Biology|September 15, 2020
BAK core dimers bind lipids and can be bridged by themAngus D Cowan, Nicholas A Smith, Jarrod J Sandow, et al.
Nature Communications|June 23, 2018
Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosisEmma J Petrie, Jarrod J Sandow, Annette V Jacobsen, et al.
Cell Reports|September 26, 2019
Viral MLKL Homologs Subvert Necroptotic Cell Death by Sequestering Cellular RIPK3Emma J Petrie, Jarrod J Sandow, Wil I L Lehmann, et al.
Nature|December 14, 2018
Structure of Plasmodium falciparum Rh5-CyRPA-Ripr invasion complexWilson Wong, Rick Huang, Sebastien Menant, et al.
Molecular Cancer Therapeutics|November 4, 2025
Discovery and characterisation of VPRBP/DCAF1 kinase inhibitor analogues as microtubular destabilising agents with potent anti-myeloma activityOlivia Susanto, Emily Gruber, Cheng Mun Wun, et al.
Science Advances|September 12, 2020
CDK13 cooperates with CDK12 to control global RNA polymerase II processivityZheng Fan, Jennifer R Devlin, Simon J Hogg, et al.
Blood Advances|October 20, 2020
Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML modelsEmma Morrish, Anthony Copeland, Donia M Moujalled, et al.
Pageof 19

Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
Nature Communications|June 21, 2020
Distinct pseudokinase domain conformations underlie divergent activation mechanisms among vertebrate MLKL orthologuesKatherine A Davies, Cheree Fitzgibbon, Samuel N Young, et al.
Nature Communications|April 14, 2021
Conformational interconversion of MLKL and disengagement from RIPK3 precede cell death by necroptosisSarah E Garnish, Yanxiang Meng, Akiko Koide, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2020
Identification of MLKL membrane translocation as a checkpoint in necroptotic cell death using MonobodiesEmma J Petrie, Richard W Birkinshaw, Akiko Koide, et al.
Nature Structural & Molecular Biology|September 15, 2020
BAK core dimers bind lipids and can be bridged by themAngus D Cowan, Nicholas A Smith, Jarrod J Sandow, et al.
Nature Communications|June 23, 2018
Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosisEmma J Petrie, Jarrod J Sandow, Annette V Jacobsen, et al.
Cell Reports|September 26, 2019
Viral MLKL Homologs Subvert Necroptotic Cell Death by Sequestering Cellular RIPK3Emma J Petrie, Jarrod J Sandow, Wil I L Lehmann, et al.
Nature|December 14, 2018
Structure of Plasmodium falciparum Rh5-CyRPA-Ripr invasion complexWilson Wong, Rick Huang, Sebastien Menant, et al.
Molecular Cancer Therapeutics|November 4, 2025
Discovery and characterisation of VPRBP/DCAF1 kinase inhibitor analogues as microtubular destabilising agents with potent anti-myeloma activityOlivia Susanto, Emily Gruber, Cheng Mun Wun, et al.
Science Advances|September 12, 2020
CDK13 cooperates with CDK12 to control global RNA polymerase II processivityZheng Fan, Jennifer R Devlin, Simon J Hogg, et al.
Blood Advances|October 20, 2020
Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML modelsEmma Morrish, Anthony Copeland, Donia M Moujalled, et al.
Pageof 19